The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
スポンサーリンク
概要
- 論文の詳細を見る
Developing effective drug therapies for arrhythmic diseases is hampered by the fact that the same drug can work well in some individuals but not in others. Human induced pluripotent stem (iPS) cells have been vetted as useful tools for drug screening. However, cardioactive drugs have not been shown to have the same effects on iPS cell-derived human cardiomyocytes as on embryonic stem (ES) cell-derived cardiomyocytes or human cardiomyocytes in a clinical setting. Here we show that current cardioactive drugs affect the beating frequency and contractility of iPS cell-derived cardiomyocytes in much the same way as they do ES cell-derived cardiomyocytes, and the results were compatible with empirical results in the clinic. Thus, human iPS cells could become an attractive tool to investigate the effects of cardioactive drugs at the individual level and to screen for individually tailored drugs against cardiac arrhythmic diseases.
論文 | ランダム
- Electronmicroscopical observations of fine silver particles obtained by the decomposition of silver oxide
- A new type of sedimentation balance
- An approach to the conversion of solar energy into an electrical energy
- 第8章 名古屋大学 (大綱化以降の学士課程カリキュラム改革 : 国立大学の事例報告)
- 人材と援助資金のフローからみた国家間関係 : ODA・留学生の流れに関するクラスター分析